Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Fish and Richardson
UBS
Queensland Health
Daiichi Sankyo
US Army
McKesson
Julphar

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019710

« Back to Dashboard

NDA 019710 describes OPTIRAY 350, which is a drug marketed by Liebel-flarsheim and is included in two NDAs. It is available from one supplier. Additional details are available on the OPTIRAY 350 profile page.

The generic ingredient in OPTIRAY 350 is ioversol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ioversol profile page.
Summary for 019710
Tradename:OPTIRAY 350
Applicant:Liebel-flarsheim
Ingredient:ioversol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019710
Mechanism of ActionX-Ray Contrast Activity
Suppliers and Packaging for NDA: 019710
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710 NDA Liebel-Flarsheim Company LLC 0019-1323 N 0019-1323-55
OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710 NDA Liebel-Flarsheim Company LLC 0019-1323 N 0019-1323-90

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength68%
Approval Date:Dec 30, 1988TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength51%
Approval Date:Dec 30, 1988TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength34%
Approval Date:Dec 30, 1988TE:RLD:No

Expired US Patents for NDA 019710

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710-003 Dec 30, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Liebel-flarsheim OPTIRAY 300 ioversol INJECTABLE;INJECTION 019710-004 Jan 22, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Liebel-flarsheim OPTIRAY 350 ioversol INJECTABLE;INJECTION 019710-005 Jan 22, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Liebel-flarsheim OPTIRAY 320 ioversol INJECTABLE;INJECTION 019710-001 Dec 30, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
Deloitte
Colorcon
Daiichi Sankyo
Argus Health
Johnson and Johnson
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.